Find the latest pharmaceutical market place for APIs enquiry about Pembrolizumab on PharmaCompass.com.

Various APIs needed in Georgia [ENA14586]

A company that deals in various pharmaceutical products is looking for suppliers of Various APIs for commercial purpose. The suppliers must support this enquiry with CoA.
1. Piperacillin + Tasobactam API
2. Imipenem + Cilastatin API
3. Sodium Bicarbonate API
4. Pantoprazole API
5. Pembrolizumab API
6. Olaparib API
7. Vandetanib API
8. Imatinib API
9. Bevacizumab API
10. Trastuzumab API

Reply

05 Aug 2022

Bangladesh Flag

Various APIs needed in Bangladesh [ENA14547]

A company that deals in export & distribution of various pharmaceutical products is looking for suppliers of Various APIs for commercial purpose. The suppliers must support this enquiry with CoA.
1. Dupilumab API
2. Omalizumab API
3. Trastuzumab API
4. Benralizumab API
5. Alirocumab API
6. Romosozumab API
7. Pembrolizumab API
8. Nivolumab API
9. Secukinumab API

Reply

02 Aug 2022

Russia-big Flag

Various APIs needed in Russia [ENA13145]

A largest pharmaceutical company that specializes in manufacturing of polymeric medical products & infusion solutions is looking for suppliers of Various APIs for both development & commercial purpose. The suppliers must support this enquiry with CoA.
1. Sterile/ Injectable Grade Aminocaproic Acid API
2. Sterile/ Injectable Grade Magnesium Sulfate API
3. Sterile/ Injectable Grade Sodium Thiosulfate API
4. Sterile/ Injectable Grade Linezolid API
5. Sterile/ Injectable Grade Adalimumab API
6. Sterile/ Injectable Grade Pembrolizumab API
7. Sterile/ Injectable Grade Nivolumab API
8. Sterile/ Injectable Grade Bevacizumab API
9. Sterile/ Injectable Grade Cetuximab API

Reply

29 Mar 2022

Various APIs needed in Brazil [ENA12413]

A company that deals in the research, development & trading of health products is looking for suppliers of Various APIs for commercial purpose. The required quantity is MOQ for each. The suppliers must support this enquiry with ANVISA, DMF, PIC/s GMP & CoA.
1. Osimertinib API
2. Ruxolitinib API
3. Apalutamide API
4. Pembrolizumab API

Reply

14 Jan 2022